Sponsored by: EVERSANA
Speakers:
Taren Grom, Co-founder and Editor, PharmaVOICE (Moderator)
Jim Burke, General Manager, Revenue Management Solutions, EVERSANA
Robert Blank, Associate Director, EVERSANA
Agnes Qerimi, Director, Government Pricing & Reporting, Alnylam Pharmaceuticals
Raymond Risman, VP, Contract Platform Technologies Engagement, HealthVerity

Join industry experts to discuss aligning net pricing with patient outcomes in this 60-minute panel.

While value-based contracting has long been heralded as a way to ensure the cost of life-changing and life-saving medicines are aligned with patient outcomes, the complexity in their implementation has limited adoption to just a few isolated examples. By confronting these obstacles directly with an integrated approach to commercialization, the mechanics of value measurement can be overcome, and these contracts can be easily applied to a wide variety of scenarios.

The panelists will share key insights on:

Identifying Viable Scenarios:  What makes a product or therapeutic class viable for value-based contracting in certain deal structures, and the obstacles  that might make a specific scenario more difficult Securing Organizational Alignment: How to align critical stakeholders to the proposed structures with detailed modeling of financial and government pricing impacts
Building Payer Engagement: How to productively engage with payers and identify willing partners to pursue these contracts.
Simplifying Adjudication and Payment: Leveraging technology to align on terms and conditions critical to the adjudication process

On Demand

About the Sponsors
EVERSANA is the leading independent provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers and payers.

For more information please visit www.eversana.com.